155 related articles for article (PubMed ID: 12482659)
21. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.
Heino P; Dillner J; Schwartz S
Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535
[TBL] [Abstract][Full Text] [Related]
22. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.
Woodham AW; Da Silva DM; Skeate JG; Raff AB; Ambroso MR; Brand HE; Isas JM; Langen R; Kast WM
PLoS One; 2012; 7(8):e43519. PubMed ID: 22927980
[TBL] [Abstract][Full Text] [Related]
23. Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.
Lin Z; Yemelyanova AV; Gambhira R; Jagu S; Meyers C; Kirnbauer R; Ronnett BM; Gravitt PE; Roden RB
Am J Pathol; 2009 Jan; 174(1):136-43. PubMed ID: 19095951
[TBL] [Abstract][Full Text] [Related]
24. Arrangement of L2 within the papillomavirus capsid.
Buck CB; Cheng N; Thompson CD; Lowy DR; Steven AC; Schiller JT; Trus BL
J Virol; 2008 Jun; 82(11):5190-7. PubMed ID: 18367526
[TBL] [Abstract][Full Text] [Related]
25. Characterizing the spatio-temporal role of sorting nexin 17 in human papillomavirus trafficking.
Bergant M; Peternel Š; Pim D; Broniarczyk J; Banks L
J Gen Virol; 2017 Apr; 98(4):715-725. PubMed ID: 28475030
[TBL] [Abstract][Full Text] [Related]
26. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.
Hagensee ME; Yaegashi N; Galloway DA
J Virol; 1993 Jan; 67(1):315-22. PubMed ID: 8380079
[TBL] [Abstract][Full Text] [Related]
27. Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products.
Wang M; Wang LL; Chen LF; Han YH; Zou YH; Si JY; Song GX
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):27-34. PubMed ID: 12518224
[TBL] [Abstract][Full Text] [Related]
28. The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors.
Darshan MS; Lucchi J; Harding E; Moroianu J
J Virol; 2004 Nov; 78(22):12179-88. PubMed ID: 15507604
[TBL] [Abstract][Full Text] [Related]
29. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
30. Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2.
Florin L; Schäfer F; Sotlar K; Streeck RE; Sapp M
Virology; 2002 Mar; 295(1):97-107. PubMed ID: 12033769
[TBL] [Abstract][Full Text] [Related]
31. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2.
Collier B; Goobar-Larsson L; Sokolowski M; Schwartz S
J Biol Chem; 1998 Aug; 273(35):22648-56. PubMed ID: 9712894
[TBL] [Abstract][Full Text] [Related]
32. Cell surface-binding motifs of L2 that facilitate papillomavirus infection.
Yang R; Day PM; Yutzy WH; Lin KY; Hung CF; Roden RB
J Virol; 2003 Mar; 77(6):3531-41. PubMed ID: 12610128
[TBL] [Abstract][Full Text] [Related]
33. Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization.
Becker KA; Florin L; Sapp C; Sapp M
Virology; 2003 Sep; 314(1):161-7. PubMed ID: 14517069
[TBL] [Abstract][Full Text] [Related]
34. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
[TBL] [Abstract][Full Text] [Related]
35. Assembly and translocation of papillomavirus capsid proteins.
Florin L; Sapp C; Streeck RE; Sapp M
J Virol; 2002 Oct; 76(19):10009-14. PubMed ID: 12208977
[TBL] [Abstract][Full Text] [Related]
36. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
37. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.
Flores ER; Allen-Hoffmann BL; Lee D; Lambert PF
J Virol; 2000 Jul; 74(14):6622-31. PubMed ID: 10864676
[TBL] [Abstract][Full Text] [Related]
38. Human Papillomavirus L2 Capsid Protein Stabilizes γ-Secretase during Viral Infection.
Crite M; DiMaio D
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458534
[TBL] [Abstract][Full Text] [Related]
39. Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins.
Buonamassa DT; Greer CE; Capo S; Yen TS; Galeotti CL; Bensi G
Virology; 2002 Feb; 293(2):335-44. PubMed ID: 11886254
[TBL] [Abstract][Full Text] [Related]
40. Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera.
Meyers C; Bromberg-White JL; Zhang J; Kaupas ME; Bryan JT; Lowe RS; Jansen KU
J Virol; 2002 May; 76(10):4723-33. PubMed ID: 11967289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
